Patents by Inventor Seth Finklestein

Seth Finklestein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9072740
    Abstract: Methods of causing an improvement in central nervous system function are provided. The methods include administering an aliquot of stem cells to the patient, the cells being derived from blood, e.g., umbilical cord blood. In some cases a growth factor is administered with the cells.
    Type: Grant
    Filed: November 19, 2012
    Date of Patent: July 7, 2015
    Assignees: The General Hospital Corporation, ViaCord LLC
    Inventors: Morey Kraus, Seth Finklestein, Paul T. Clark
  • Patent number: 8337833
    Abstract: Methods of causing an improvement in central nervous system function are provided. The methods include administering an aliquot of stem cells to the patient, the cells being derived from blood, e.g., umbilical cord blood. In some cases a growth factor is administered with the cells.
    Type: Grant
    Filed: May 11, 2010
    Date of Patent: December 25, 2012
    Assignees: The General Hospital Corp., ViaCord, LLC
    Inventors: Morey Kraus, Seth Finklestein, Paul Clark
  • Publication number: 20100322899
    Abstract: Methods of causing an improvement in central nervous system function are provided. The methods include administering an aliquot of stem cells to the patient, the cells being derived from blood, e.g., umbilical cord blood. In some cases a growth factor is administered with the cells.
    Type: Application
    Filed: May 11, 2010
    Publication date: December 23, 2010
    Applicant: VIACELL, INC.
    Inventors: Morey Kraus, Seth Finklestein, Paul Clark
  • Patent number: 7811557
    Abstract: Methods of causing an improvement in central nervous system function are provided. The methods include administering an aliquot of stem cells to the patient, the cells being derived from blood, e.g., umbilical cord blood. In some cases a growth factor is administered with the cells.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: October 12, 2010
    Assignees: Viacell, Inc., The General Hospital Corp.
    Inventors: Morey Kraus, Seth Finklestein, Paul Clark
  • Publication number: 20050069526
    Abstract: Methods, kits and compositions for improving a subject's recovery from CNS injury are disclosed. In certain aspects, a method may include administering to a subject cells and a neural stimulant. Recovery may be manifest by improvements in sensorimotor or cognitive abilities, e.g., improved limb movement and control or improved speech capability. In certain embodiments, subject methods can be used as part of a treatment for damage resulting from ischemia, hypoxia or trauma.
    Type: Application
    Filed: September 30, 2003
    Publication date: March 31, 2005
    Inventors: Seth Finklestein, Evan Snyder